During the past decade, Hospital Royo Villanova conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Royo Villanova" #1 sponsor was "PETHEMA Foundation" with 3 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 1 trials sponsored and "Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Royo Villanova" #1 collaborator was "Hospital Miguel Servet" with 2 trials as a collaborator, "Hospital Royo Villanova" with 2 trials as a collaborator, "Universidad de Zaragoza" with 2 trials as a collaborator, "Clinica Quiron de Zaragoza" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Royo Villanova" are "Multiple Myeloma" (3 trials), "Acute Respiratory Failure" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Atrial Fibrillation" (1 trials) and "Colorectal Surgery" (1 trials). Many other conditions were trialed in "Hospital Royo Villanova" in a lesser frequency.

Most popular intervention types in "Hospital Royo Villanova" are "Drug" (7 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Asynchronous telerehabilitation programme" (1 trials), "Belantamab mafodotin" (1 trials), "Ceftriaxone intravenous" (1 trials), "Colorectal Surgery" (1 trials) and "Donepezil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Royo Villanova" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Royo Villanova". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hospital Royo Villanova, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Royo Villanova, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".